GW-SEM
GW-SEM integrates structural equation modeling (SEM) into genome-wide association studies (GWAS) to test associations between single nucleotide polymorphisms (SNPs) and multivariate phenotypes or latent constructs.
Key Features:
- Efficient SEM integration: Fits SEMs across the genome to enable testing of complex relationships between SNPs and phenotypic traits.
- Diagonally Weighted Least Squares (DWLS) estimator: Employs a DWLS estimator to fit models with robust parameter estimation and p-value calculation that align closely with full information maximum likelihood methods.
- Supported SEM models: Implements four common SEMs: one-factor model, one-factor residuals model, two-factor model, and latent growth model.
- Comprehensive phenotypic analysis: Accommodates multivariate phenotypes and latent constructs to address stochastic variance in complex traits.
- Performance evaluation: Demonstrated computational efficiency and statistical power through simulations, timing analyses, and comparisons with existing multivariate GWAS software.
Scientific Applications:
- Psychiatric and substance use research: Enables investigation of comorbid traits and complex phenotypic architectures in psychiatric disorders and substance use studies.
- Behavioral genetics: Supports exploration of genetic influences on behavioral traits via multivariate and latent-variable modeling.
Methodology:
Associations between SNPs and multiple phenotypes or latent constructs are tested using SEMs fit genome-wide with a diagonally weighted least squares (DWLS) estimator, and performance is evaluated via simulations and power analyses.
Topics
Details
- License:
- Unlicense
- Maturity:
- Mature
- Cost:
- Free of charge
- Tool Type:
- command-line tool
- Operating Systems:
- Linux, Windows, Mac
- Programming Languages:
- R
- Added:
- 8/7/2018
- Last Updated:
- 6/16/2020
Operations
Publications
Verhulst B, Maes HH, Neale MC. GW-SEM: A Statistical Package to Conduct Genome-Wide Structural Equation Modeling. Behavior Genetics. 2017;47(3):345-359. doi:10.1007/s10519-017-9842-6. PMID:28299468. PMCID:PMC5423544.
PMID: 28299468
PMCID: PMC5423544
Funding: - National Institute of Drug Abuse: DA024413, R01-DA018673, R25-026119